115 related articles for article (PubMed ID: 17672)
1. Carrageenan and thrombin trigger prostaglandin synthetase-independent aggregation of rabbit platelets: inhibition by phospholipase A2 inhibitors.
Vargaftig BB
J Pharm Pharmacol; 1977 Apr; 29(4):222-8. PubMed ID: 17672
[TBL] [Abstract][Full Text] [Related]
2. Involvement of mediators in the interaction of platelets and carrageenan.
Vargaftig BB
Agents Actions Suppl; 1977; 2():9-39. PubMed ID: 415534
[TBL] [Abstract][Full Text] [Related]
3. Carrageenan-induced activation of human platelets is independent of phospholipase A2 and of formation of thromboxanes.
Vargaftig BB; Fouque F; Chignard M; Dumarey C
J Pharm Pharmacol; 1980 Nov; 32(11):740-5. PubMed ID: 6110720
[TBL] [Abstract][Full Text] [Related]
4. Cyclooxygenase--independent pathway of phospholipase activation in carrageenan--induced platelet aggregation.
Yeh HI; Chen IJ; Teng CM
Thromb Res; 1987 Jan; 45(1):39-49. PubMed ID: 3105112
[TBL] [Abstract][Full Text] [Related]
5. Effects of prostaglandin synthetase inhibitors and of other drugs on aggregation of plasma-free rabbit platelets by carrageenan and by thrombin [proceedings].
Vargaftig BB
Br J Pharmacol; 1976 Nov; 58(3):448P. PubMed ID: 825176
[No Abstract] [Full Text] [Related]
6. Cyclic adenosine 3',5'-monophosphate inhibits the availability of arachidonate to prostaglandin synthetase in human platelet suspensions.
Minkes M; Stanford N; Chi MM; Roth GJ; Raz A; Needleman P; Majerus PW
J Clin Invest; 1977 Mar; 59(3):449-54. PubMed ID: 190267
[TBL] [Abstract][Full Text] [Related]
7. Carrageenan-induced activation of human platelets is dependent on the phospholipase C pathway.
Hatmi M; Randon J; Faili A; Vargaftig BB
Br J Haematol; 1993 Feb; 83(2):270-5. PubMed ID: 8457475
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of phospholipase A2 by tiaramide in rabbit platelets.
Takano S
Jpn J Pharmacol; 1985 Nov; 39(3):307-16. PubMed ID: 3005729
[TBL] [Abstract][Full Text] [Related]
9. Biphasic effect on platelet aggregation by phospholipase a purified from Vipera russellii snake venom.
Teng CM; Chen YH; Ouyang C
Biochim Biophys Acta; 1984 May; 772(3):393-402. PubMed ID: 6426517
[TBL] [Abstract][Full Text] [Related]
10. Anti-inflammatory and platelet anti-aggregant activity of phospholipase-A2 inhibitors.
Vallee E; Gougat J; Navarro J; Delahayes JF
J Pharm Pharmacol; 1979 Sep; 31(9):588-92. PubMed ID: 41058
[TBL] [Abstract][Full Text] [Related]
11. Studies on the incorporation of [1-14C]arachidonic acid into glycerolipids and its conversion into prostaglandins by rabbit iris. Effects of anti-inflammatory drugs and phospholipase A2 inhibitors.
Abdel-Latif AA; Smith JP
Biochim Biophys Acta; 1982 Jun; 711(3):478-89. PubMed ID: 6809058
[TBL] [Abstract][Full Text] [Related]
12. Prostaglandin endoperoxides, thromboxane A2 and adenosine diphosphate in collagen-induced aggregation of rabbit platelets.
Lewis GP; Watts IS
Br J Pharmacol; 1982 Apr; 75(4):623-31. PubMed ID: 6802211
[TBL] [Abstract][Full Text] [Related]
13. [Inhibitory effect of various traditional Chinese medicines on rabbit platelet phospholipase A2 in vitro and suppressive effect of tôki-syakuyaku-san on increased aggregability in hypercholesterolemic rabbit ex vivo].
Sato T; Yamaguchi H; Fujii T; Akiba S; Tamura A; Fujii T; Tatsumi Y; Miura O
Yakugaku Zasshi; 1989 Nov; 109(11):869-76. PubMed ID: 2614670
[TBL] [Abstract][Full Text] [Related]
14. Interference of bromophenacyl bromide with platelet phospholipase A2 activity induced by thrombin and by the ionophore A23187.
Vargaftig BB; Fouque F; Chignard M
Thromb Res; 1980 Jan 1-15; 17(1-2):91-102. PubMed ID: 6246654
[No Abstract] [Full Text] [Related]
15. Arachidonate metabolism, 5-hydroxytryptamine release and aggregation in human platelets activated by palmitaldehyde acetal phosphatidic acid.
Brammer JP; Maguire MH
Br J Pharmacol; 1984 May; 82(1):61-72. PubMed ID: 6428500
[TBL] [Abstract][Full Text] [Related]
16. Signal transduction by the platelet Fc receptor.
Anderson GP; Anderson CL
Blood; 1990 Sep; 76(6):1165-72. PubMed ID: 2144775
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of prostaglandin synthetase and carrageenan-induced edema by tricyclic analogs of flufenamic acid.
Horodniak JW; Matz ED; Walz DT; Sutton BM; Berkoff CE; Zarembo JE; Bender AD
Res Commun Chem Pathol Pharmacol; 1975 Aug; 11(4):533-42. PubMed ID: 809819
[TBL] [Abstract][Full Text] [Related]
18. The distribution and metabolism of arachidonic acid in rabbit platelets during aggregation and its modification by drugs.
Blackwell GJ; Duncombe WG; Flower RJ; Parsons MF; Vane JR
Br J Pharmacol; 1977 Feb; 59(2):353-66. PubMed ID: 837023
[TBL] [Abstract][Full Text] [Related]
19. Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways.
Krishnamurthi S; Westwick J; Kakkar VV
Biochem Pharmacol; 1984 Oct; 33(19):3025-35. PubMed ID: 6091666
[TBL] [Abstract][Full Text] [Related]
20. Stereoisomeric relationships among anti-inflammatory activity, inhibition of platelet aggregation, and inhibition of prostaglandin synthetase.
Gaut ZN; Baruth H; Randall LO; Ashley C; Paulsrud JR
Prostaglandins; 1975 Jul; 10(1):59-66. PubMed ID: 807954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
